Business : Fortrea To Acquire Worldwideâs Early Phase Business
KUALA LUMPUR, Sept 3 (Bernama) -- Fortrea and Worldwide Clinical Trials (Worldwide) have signed a definitive agreement under which Fortrea will acquire Worldwide’s Early Phase Services division (Early Phase) in an all-cash transaction valued at approximately US$45 million. (US$1=RM4.03)
We haven't written up this one. Bernama has the full story — the link below goes straight to it.